Safety and Efficacy of RRx-001 in the Attenuation of Oral Mucositis in Patients Receiving Chemoradiation for the Treatment of Oral Cancers Read more about Safety and Efficacy of RRx-001 in the Attenuation of Oral Mucositis in Patients Receiving Chemoradiation for the Treatment of Oral Cancers
The REPLACE Registry for Cholbam® (Cholic Acid) Read more about The REPLACE Registry for Cholbam® (Cholic Acid)
A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease Read more about A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease
Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis Read more about Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
S1417CD Financial Impact Assessment Tool in Patients With Metastatic Colorectal Cancer Read more about S1417CD Financial Impact Assessment Tool in Patients With Metastatic Colorectal Cancer
Study to Assess Safety, Tolerability and Clinical Activity of BGB-290 in Combination With Temozolomide (TMZ) in Participants With Locally Advanced or Metastatic Solid Tumors Read more about Study to Assess Safety, Tolerability and Clinical Activity of BGB-290 in Combination With Temozolomide (TMZ) in Participants With Locally Advanced or Metastatic Solid Tumors
Intranasal Oxytocin vs. Placebo for the Treatment of Hyperphagia in Prader-Willi Syndrome Read more about Intranasal Oxytocin vs. Placebo for the Treatment of Hyperphagia in Prader-Willi Syndrome
Fresh Frozen Plasma as a Substitute for Albumin in Patients Receiving a Large Volume Paracentesis Read more about Fresh Frozen Plasma as a Substitute for Albumin in Patients Receiving a Large Volume Paracentesis
Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA Read more about Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA
A Study of TSR-022 in Participants With Advanced Solid Tumors (AMBER) Read more about A Study of TSR-022 in Participants With Advanced Solid Tumors (AMBER)